<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow, Inc.

    Unlimited Tomorrow is here to change the way we think about artificial limbs. They...

    Unlimited Tomorrow is here to change the way we...

    Amount Raised:    $883,964.00
    Fundraising Status:    EC
    Filing Type:    CF
    Elevate Nutrition Inc.

    Elevate Nutrition Inc.

    Elevate is the first of its kind, a line of high-performance nutritional supplemen...

    Elevate is the first of its kind, a line of hig...

    Amount Raised:    $156,102.00
    Fundraising Status:    EC
    Filing Type:    CF
    Quidel Corporation

    Quidel Corporation

    Quidel Corporation (Nasdaq: QDEL) is a California-based leading manufacturer of di...

    Quidel Corporation (Nasdaq: QDEL) is a Californ...

    Filing Type:    PU
    Ardelyx, Inc.

    Ardelyx, Inc.

    Ardelyx is focused on enhancing the way people with cardiorenal diseases are treat...

    Ardelyx is focused on enhancing the way people ...

    Filing Type:    PU
    NextCure, Inc.

    NextCure, Inc.

    NextCure is a clinical-stage biopharmaceutical company committed to discovering an...

    NextCure is a clinical-stage biopharmaceutical ...

    Filing Type:    PU
    Neurocarrus Inc

    Neurocarrus Inc

    Neurocarrus is developing a breakthrough therapy ( N-001 ) to fulfill the unmet ne...

    Neurocarrus is developing a breakthrough therap...

    Amount Raised:    $344,168.00
    Fundraising Status:    EC
    Filing Type:    CF
    Alpine Immune Sciences, Inc.

    Alpine Immune Sciences, Inc.

    Alpine is a development-stage specialty pharmaceutical company focused on discover...

    Alpine is a development-stage specialty pharmac...

    Filing Type:    PU
    Surface Oncology, Inc.

    Surface Oncology, Inc.

    Surface Oncology is an immuno-oncology company on a mission to break through and d...

    Surface Oncology is an immuno-oncology company ...

    Filing Type:    PU
    TRACON Pharmaceuticals, Inc.

    TRACON Pharmaceuticals, Inc.

    TRACON Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused...

    TRACON Pharmaceuticals, Inc. is a clinical stag...

    Filing Type:    PU
    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc.

    Corbus Pharmaceuticals Holdings, Inc. is a Phase 3 clinical-stage pharmaceutical c...

    Corbus Pharmaceuticals Holdings, Inc. is a Phas...

    Filing Type:    PU
    Viela Bio, Inc.

    Viela Bio, Inc.

    Viela is dedicated to the development and commercialization of novel, life-changin...

    Viela is dedicated to the development and comme...

    Filing Type:    PU
    Phormed Inc

    Phormed Inc

    PhorMed is a clinical stage biopharmaceutical company located in Beverly Hills Cal...

    PhorMed is a clinical stage biopharmaceutical c...

    Amount Raised:    $128,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    ©2026 National Investor Network. All Rights Reserved.